OCIAD2 and carcinoma: Unlike earlier studies, wherein carcinoma cells (HeLa) were transfected with GFP/RFP-tagged constructs of OCIAD2 in combination with reporter-tagged intracellular markers19, our approach avoids bias or mis-localization and informs about the subcellular localization of OCIAD2.